產(chǎn)品詳情
簡(jiǎn)單介紹:
V-MafMusculoaponeuroticFibrosarcomaOncogeneHomologG(Avian)(Mafg)(MiddleRegion)Peptide
詳情介紹:
Blocked Antibody | anti-Mafg antibody (V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog G (Avian)) (Middle Region) (ABIN2777530) |
Characteristics | This is a synthetic peptide designed for use in combination with anti-MAFG antibody (Catalog #: ARP32691_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. |
Purification | Purified |
Background |
Since they lack a putative transactivation domain, the small Mafs behave as transcriptional repressors when they dimerize among themselves. However, they seem to serve as transcriptional activators by dimerizing with other (usually larger) basic-zipper proteins and recruiting them to specific DNA-s. Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor. Transcription factor, component of erythroid-specific transcription factor NF-E2. Alias Symbols: MGC13090, MGC20149, hMAF Protein Interaction Partner: C7orf64,CHD3,CREBBP,HOXD12,MAF,MAFG,MED31,NFE2,NFE2L1,NFE2L2,PAX6,PRRX1,VIM,C7orf64,CHD3,HOXD12,MAF,MAFG,MED31,NFE2,NFE2L1,VIM Protein Size: 162 |
Molecular Weight | 18 kDa |
Gene ID | 4097 |
NCBI Accession | NM_002359, NP_002350 |
UniProt | O15525 |
Research Area | Transcription Factors |
Application Notes | Each Investigator should determine their own optimal working dilution for specific applications. |
Restrictions | For Research Use only |
Format | Lyophilized |
Reconstitution | Add 100?μL of sterile PBS. Final peptide concentration is 1?mg/mL in PBS. |
Concentration | 1 mg/mL |
Buffer | Final peptide concentration is 1 mg/mL in PBS. |
Handling Advice | Avoid repeated freeze-thaw cycles. |
Storage | -20 °C |
Storage Comment | For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles. |